Omnio (Drug Discovery) Overview
- Founded
-
2006
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$618K
- Investors
-
1
Omnio (Drug Discovery) General Information
Description
Developer of therapies for wound healing and anti-infection management. The company develops recombinant human plasminogen that helps in wound healing and offers its product in the form of ear drops for tympanic membrane perforation, enabling people to get rid of irritations.
Contact Information
Website
www.omnio.se
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
- Uminova Science Park
- Tvistevägen 48
- 907 19 Umea
- Sweden
+46 073-620 00 00
Omnio (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 06-Dec-2021 | $618K | 00.000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 00.000 | 00.000 | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Omnio (Drug Discovery) Patents
Omnio (Drug Discovery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180326023-A1 | Plasminogen dosage regimen for wound healing | Abandoned | 10-Nov-2015 | 0000000000 | 0 |
| JP-2018534306-A | Plasminogen administration plan for wound healing | Pending | 10-Nov-2015 | 0000000000 | |
| EP-3373957-A1 | Plasminogen dosage regimen for wound healing | Withdrawn | 10-Nov-2015 | 0000000000 | |
| AU-2016352183-A1 | Plasminogen dosage regimen for wound healing | Abandoned | 10-Nov-2015 | 0000000000 | |
| CA-3004509-A1 | Plasminogen dosage regimen for wound healing | Pending | 10-Nov-2015 | A61K38/484 |
Omnio (Drug Discovery) Executive Team (4)
Omnio (Drug Discovery) Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Lars Johansson | Omnio (Drug Discovery) | Chairman of the Board | 000 0000 |
| Lars Ohman | Self | Board Member | 000 0000 |
| Stefan Nilsson | Self | Board Member | 000 0000 |
| Tor Ny Ph.D | Omnio (Drug Discovery) | Co-Founder, Head of Research & Development & Board Member | 000 0000 |
Omnio (Drug Discovery) Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Umeå Biotech Incubator | Accelerator/Incubator | 000 0000 | 000000 0 |